Opinion
Video
Author(s):
Experts on graft-vs-host disease (GvHD) introduce themselves and provide an overview of GvHD, highlighting diagnosis, symptoms, risk stratification, and prevention.
Long-Term Data for Up-Front Combinations Reaffirm Treatment Options in CLL
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Enhancing the Referral Process for Genetic Testing Represents Key Next Step in Breast Cancer
Revisit the OncLive On Air Episodes From February 2024
SL-172154 Receives FDA Orphan Drug Designation in AML
Most Young Breast Cancer Survivors Can Have Children
Talquetamab Produces Responses in R/R Myeloma After Prior T-Cell–Directed Therapies
Lurbinectedin Plus Irinotecan Is Safe, Prolongs Responses in High-Risk, Pretreated SCLC
Axi-Cel Shows Safety, Clinical Activity in R/R Primary and Secondary CNS Lymphomas
Amphiphile Lymph Node–Targeted Vaccine Is Safe and Bolsters T-Cell Responses in MRD+ PDAC and CRC